vfa Forecasts German Pharma Output to Fall 2.2% in 2026

Bitget2026/10/23 09:40

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

German pharmaceutical production is forecast to fall 2.2% in 2026, before rebounding 4.3% in 2027, largely on catch-up effects.
Pharmaceutical investment spending is projected to decline 1.8% in nominal terms in 2027 as statutory cost-cutting measures squeeze profitability.
Cumulative capital investment and research spending could be more than €4 billion below levels without the additional burdens by 2030.
The mandatory manufacturer rebate on patent-protected medicines rises from 7% to 15.5% at the start of 2027, reducing investment returns.
Germany’s economy is forecast to grow 1.3% in 2026, slowing to 1.1% in 2027, with private investment remaining weak.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioM Biotech Cluster Development GmbH published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

vfa Forecasts German Pharma Output to Fall 2.2% in 2026

You may also like

Crypto prices